# CTO Andrea Alesini

**Type:** Institutions  
**Canonical URL:** https://scholariq.org/institutions/cto-andrea-alesini/

## Facts

| Field | Value |
| --- | --- |
| Avg h-index | 53.6 |
| Citations | 156,666 |
| City | Rome |
| Country | IT |
| Description | CTO Andrea Alesini is a research organisation in Rome, IT. OpenAlex records 3,311 works and 156,666 citations for it. 874 researchers list it as their most recent affiliation. |
| Homepage | http://www.aslrmc.com/ |
| OpenAlex ID | https://openalex.org/I4210116892 |
| Researchers | 874 |
| ROR ID | https://ror.org/02frwff62 |
| Type | healthcare |
| Works | 3,311 |

## University papers

Showing 12 of 41.

- [Fractional Flow Reserve–Guided PCI versus Medical Therapy in Stable Coronary Disease](https://scholariq.org/papers/fractional-flow-reserve-guided-pci-versus-medical-therapy-in-stable-coronary/)
- [Gastroenteropancreatic neuroendocrine tumours](https://scholariq.org/papers/gastroenteropancreatic-neuroendocrine-tumours/)
- [Everolimus for the treatment of advanced, non-functional neuroendocrine tumours of the lung or gastrointestinal tract (RADIANT-4): a randomised, placebo-controlled, phase 3 study](https://scholariq.org/papers/everolimus-for-the-treatment-of-advanced-non-functional-neuroendocrine-tumours/)
- [Fractional Flow Reserve–Guided PCI for Stable Coronary Artery Disease](https://scholariq.org/papers/fractional-flow-reserve-guided-pci-for-stable-coronary-artery-disease/)
- [Prediction of outcome in individuals with diabetic foot ulcers: focus on the differences between individuals with and without peripheral arterial disease. The EURODIALE Study](https://scholariq.org/papers/prediction-of-outcome-in-individuals-with-diabetic-foot-ulcers-focus-on-the/)
- [High prevalence of ischaemia, infection and serious comorbidity in patients with diabetic foot disease in Europe. Baseline results from the Eurodiale study](https://scholariq.org/papers/high-prevalence-of-ischaemia-infection-and-serious-comorbidity-in-patients-with/)
- [A Genotype-Guided Strategy for Oral P2Y <sub>12</sub> Inhibitors in Primary PCI](https://scholariq.org/papers/a-genotype-guided-strategy-for-oral-p2y-sub-12-sub-inhibitors-in-primary-pci/)
- [Prognostic Value of Fractional Flow Reserve](https://scholariq.org/papers/prognostic-value-of-fractional-flow-reserve/)
- [Fractional flow reserve versus angiography for guidance of PCI in patients with multivessel coronary artery disease (FAME): 5-year follow-up of a randomised controlled trial](https://scholariq.org/papers/fractional-flow-reserve-versus-angiography-for-guidance-of-pci-in-patients-with/)
- [The Charcot Foot in Diabetes](https://scholariq.org/papers/the-charcot-foot-in-diabetes/)
- [Pancreatic Endocrine Tumors: Expression Profiling Evidences a Role for AKT-mTOR Pathway](https://scholariq.org/papers/pancreatic-endocrine-tumors-expression-profiling-evidences-a-role-for-akt-mtor/)
- [European experts consensus statement on cystic tumours of the pancreas](https://scholariq.org/papers/european-experts-consensus-statement-on-cystic-tumours-of-the-pancreas/)

## University researchers

- [Luigi Uccioli](https://scholariq.org/researchers/luigi-uccioli/)
- [Flaminia Coluzzi](https://scholariq.org/researchers/flaminia-coluzzi/)

## University top topics

Showing 8 of 25.

- [Migraine and Headache Studies](https://scholariq.org/topics/migraine-and-headache-studies/)
- [Cancer Immunotherapy and Biomarkers](https://scholariq.org/topics/cancer-immunotherapy-and-biomarkers/)
- [COVID-19 Clinical Research Studies](https://scholariq.org/topics/covid-19-clinical-research-studies/)
- [Atrial Fibrillation Management and Outcomes](https://scholariq.org/topics/atrial-fibrillation-management-and-outcomes/)
- [Cardiac Imaging and Diagnostics](https://scholariq.org/topics/cardiac-imaging-and-diagnostics/)
- [Pancreatic and Hepatic Oncology Research](https://scholariq.org/topics/pancreatic-and-hepatic-oncology-research/)
- [Neurological disorders and treatments](https://scholariq.org/topics/neurological-disorders-and-treatments/)
- [Multiple Sclerosis Research Studies](https://scholariq.org/topics/multiple-sclerosis-research-studies/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.